TULANE TALK
May 30, 2001
Good Morning:
I’m pleased to report that we have named Dr. Andrew Lackner, Associate Professor of Pathology at Harvard Medical School and Chairman of the Division of Comparative Pathology at the New England Regional Primate Research Center, as the new Director of Tulane’s Regional Primate Research Center.
Andrew holds a doctorate in veterinary medicine from Colorado State University and a Ph.D in comparative pathology from the University of California, Davis. He has held several academic appointments at primate centers throughout the country, including the California Regional Primate Research Center at the University of California, Davis and the New Mexico Regional Primate Research Laboratory at New Mexico State University.
Andrew’s academic and administrative experiences are ideal for this position. His scholarly record and accomplishments are very impressive as is his academic administrative experience at the New Regional England Primate Center, one of the premier centers of its kind in the U.S.
Andrew will replace Dr. Peter Gerone who has headed our primate research center, the largest federally funded primate center in the country, since 1971. Under Pete’s leadership the center has achieved many research “firsts” in the field of AIDS, leprosy, Lyme disease, kidney disease and other ailments. He has also bravely weathered more than a little controversy from those who oppose animal research. Although he has been trying to “retire” since the summer of 1998, Pete graciously agreed to continue in his position until a successor was named. This is typical of Pete’s dedication. His enthusiasm, amiability, visionary leadership and research contributions in the service of humanity have long been admired and will always be remembered by everyone at Tulane.
Finally, I would like to thank Dr. Paul Whelton, Senior Vice President for Health Sciences, Dr. Donald Krogstad, Chair of the Primate Center search committee and the entire search committee for their dedication in making such a stellar selection.